Charles River Laboratories International, Inc. (CRL) Financial Statements (2023 and earlier)

Company Profile

Business Address 251 BALLARDVALE ST
WILMINGTON, MA 01887
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments195201243242214224466
Cash and cash equivalents194200242241213223465
Short-term investments1111111
Restricted cash and investments1604434
Receivables778755707650660644611
Inventory, net of allowances, customer advances and progress billings262257221199182194194
Inventory262257221199182194194
Prepaid expense92819094788582
Disposal group, including discontinued operation    140  
Other undisclosed current assets8793718510211867
Total current assets:1,4151,3931,3331,2741,3791,2681,423
Noncurrent Assets
Finance lease, right-of-use asset    303231
Operating lease, right-of-use asset373382305293285277198
Intangible assets, net (including goodwill)3,7443,8933,7163,7733,8363,5972,686
Goodwill2,7762,8602,6962,7122,7362,5401,891
Intangible assets, net (excluding goodwill)9681,0321,0201,0611,1001,057796
Deferred income tax assets40424340413235
Other noncurrent assets430436357353341358349
Other undisclosed noncurrent assets1,3811,3831,3221,2911,1461,1571,086
Total noncurrent assets:5,9676,1365,7425,7505,6795,4524,386
TOTAL ASSETS:7,3837,5297,0757,0247,0586,7205,809
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities626660618673596563490
Accounts payable182211226198128111127
Accrued liabilities197199227229245229198
Employee-related liabilities200203165246223223165
Taxes payable4746     
Deferred revenue251242228220222231213
Debt2233233
Other liabilities18219014513816413297
Other undisclosed current liabilities(47)(46)     
Total current liabilities:1,0141,0489941,033984930803
Noncurrent Liabilities
Long-term debt and lease obligation, including:2,9372,9972,6762,6642,8932,7272,202
Finance lease, liability   25262626
Operating lease, liability369366264253244239173
Other undisclosed long-term debt and lease obligation2,5682,6312,4122,3862,6232,4622,003
Liabilities, other than long-term debt391425470583473470414
Deferred income tax liabilities196230231240259263207
Liability, pension and other postretirement and postemployment benefits   75   
Other liabilities195195239243214207207
Business combination, contingent consideration, liability   25   
Other undisclosed noncurrent liabilities369366264153244239173
Total noncurrent liabilities:3,6973,7883,4103,3993,6103,4372,789
Total liabilities:4,7114,8364,4044,4324,5944,3663,593
Temporary equity, carrying amount39405653333128
Stockholders' equity
Stockholders' equity attributable to parent2,6272,6482,6102,5352,4272,3182,184
Common stock1111111
Treasury stock, value(38)(38)(34) (40)(40)(36)
Additional paid in capital1,7811,7611,7451,7181,7201,6911,660
Accumulated other comprehensive loss(396)(259)(175)(165)(133)(108)(127)
Retained earnings1,2801,1831,074981879775687
Stockholders' equity attributable to noncontrolling interest6554554
Total stockholders' equity:2,6332,6532,6152,5392,4322,3232,188
TOTAL LIABILITIES AND EQUITY:7,3837,5297,0757,0247,0586,7205,809

Income Statement (P&L) ($ in millions)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
Revenues989973914905896915825
Gross profit:989973914905896915825
Operating expenses(219)(169)(188)(174)(181)(204)(185)
Other undisclosed operating loss(619)(616)(577)(558)(559)(573)(516)
Operating income:151187149173156138124
Nonoperating income (expense)(16)(40)(42)20(16)6(44)
Investment income, nonoperating00(14)1800(17)
Other nonoperating income (expense)(17)(40)(29)2(16)6(28)
Interest and debt expense(11)(4)(10)17(16)(16)(57)
Income from continuing operations before income taxes:1231449621012312723
Income tax expense(25)(33)(16)(24)(18)(38)(2)
Income before gain (loss) on sale of properties:98111801861059020
Other undisclosed net income (loss)  15(46)  44
Net income:98111951401059064
Net loss attributable to noncontrolling interest(1)(1)(2)(2)(2)(1)(2)
Net income available to common stockholders, diluted:96109931381038862

Comprehensive Income ($ in millions)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
Net income:98111951401059064
Other comprehensive income (loss)(137)(84)(10)2(25)19 
Other undisclosed comprehensive loss   (29)   
Comprehensive income (loss):(39)27851138010964
Comprehensive income (loss), net of tax, attributable to noncontrolling interest11(2)(3)(2)(2)(2)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(2)(3)0(5)(0)012
Comprehensive income (loss), net of tax, attributable to parent:(41)26831067910773

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: